MUST | Low risk (N = 17 547) | Intermediate risk (N = 1899) | High risk (N = 2530) | P value | |||||
Baseline characteristic | |||||||||
Age mean (SD)● | 55.9 (20.4) | 57.6 (20.4) | 55.9 (20.4) | .002 | |||||
Sex (female) N (%)□ | 7229 (41.2) | 765 (40.3) | 1043 (41.2) | .74 | |||||
Charlson comorbidity index mean (SD)● | 3.7 (1.9) | 3.6 (1.8) | 3.8 (2.0) | .002 | |||||
HFRS mean (SD)● | 4.7 (4.3) | 4.4 (4.2) | 5.0 (4.4) | <.001 | |||||
Indigenous statusa (N)%□ | 779 (4.4) | 95 (5.0) | 219 (8.7) | <.001 | |||||
SEIFA IRSD decile mean (SD)● | 4.6 (2.8) | 4.5 (2.6) | 4.3 (2.9) | <.001 | |||||
Outcome | |||||||||
Low vs intermediate Mean ratio/odds ratio (95% CI) | P value | High vs intermediate Mean ratio/odds ratio (95% CI) | P value | High vs low Mean ratio/odds ratio (95% CI) | P value | ||||
LOS hours mean (SD) unadjusted | 155.2 (220.3) | 210.3 (323.2) | 0.83 (0.79, 0.87) | <.001 | 263.3 (355.9) | 1.20 (1.13, 1.27) | <.001 | 1.44 (1.39, 1.50) | <.001 |
LOS hours mean (SD) adjusted | 0.88 (0.84, 0.91) | <.001 | 1.13 (1.07, 1.19) | <.001 | 1.29 (1.25, 1.34) | <.001 | |||
30-Day readmission, N (%) unadjusted | 3500 | 436 | 0.90 (0.88, 0.91) | <.001 | 748 | 1.34 (1.23, 1.46) | <.001 | 1.50 (1.36, 1.65) | <.001 |
30-Day readmission, N (%) adjusted | 0.97 (0.89, 1.04) | .37 | 1.24 (1.18, 1.30) | <.001 | 1.29 (1.16, 1.42) | <.001 | |||
Inpatient mortality, N (%) unadjusted | 101 | 18 | 0.74 (0.63, 0.89) | .0008 | 53 | 1.86 (1.60, 2.17) | <.001 | 2.50 (2.10, 2.98) | <.001 |
Inpatient mortality, N (%) adjusted | 0.87 (0.76, 1.00) | .05 | 1.35 (1.12, 1.64) | .002 | 1.55 (1.26, 1.91) | <.001 |
MUST | Low risk (N = 17 547) | Intermediate risk (N = 1899) | High risk (N = 2530) | P value | |||||
Baseline characteristic | |||||||||
Age mean (SD)● | 55.9 (20.4) | 57.6 (20.4) | 55.9 (20.4) | .002 | |||||
Sex (female) N (%)□ | 7229 (41.2) | 765 (40.3) | 1043 (41.2) | .74 | |||||
Charlson comorbidity index mean (SD)● | 3.7 (1.9) | 3.6 (1.8) | 3.8 (2.0) | .002 | |||||
HFRS mean (SD)● | 4.7 (4.3) | 4.4 (4.2) | 5.0 (4.4) | <.001 | |||||
Indigenous statusa (N)%□ | 779 (4.4) | 95 (5.0) | 219 (8.7) | <.001 | |||||
SEIFA IRSD decile mean (SD)● | 4.6 (2.8) | 4.5 (2.6) | 4.3 (2.9) | <.001 | |||||
Outcome | |||||||||
Low vs intermediate Mean ratio/odds ratio (95% CI) | P value | High vs intermediate Mean ratio/odds ratio (95% CI) | P value | High vs low Mean ratio/odds ratio (95% CI) | P value | ||||
LOS hours mean (SD) unadjusted | 155.2 (220.3) | 210.3 (323.2) | 0.83 (0.79, 0.87) | <.001 | 263.3 (355.9) | 1.20 (1.13, 1.27) | <.001 | 1.44 (1.39, 1.50) | <.001 |
LOS hours mean (SD) adjusted | 0.88 (0.84, 0.91) | <.001 | 1.13 (1.07, 1.19) | <.001 | 1.29 (1.25, 1.34) | <.001 | |||
30-Day readmission, N (%) unadjusted | 3500 | 436 | 0.90 (0.88, 0.91) | <.001 | 748 | 1.34 (1.23, 1.46) | <.001 | 1.50 (1.36, 1.65) | <.001 |
30-Day readmission, N (%) adjusted | 0.97 (0.89, 1.04) | .37 | 1.24 (1.18, 1.30) | <.001 | 1.29 (1.16, 1.42) | <.001 | |||
Inpatient mortality, N (%) unadjusted | 101 | 18 | 0.74 (0.63, 0.89) | .0008 | 53 | 1.86 (1.60, 2.17) | <.001 | 2.50 (2.10, 2.98) | <.001 |
Inpatient mortality, N (%) adjusted | 0.87 (0.76, 1.00) | .05 | 1.35 (1.12, 1.64) | .002 | 1.55 (1.26, 1.91) | <.001 |
aInclusive of ‘Aboriginal’, ‘Aboriginal and Torres Strait Islander’ and ‘Torres Strait Islander’
●Analysis of variance, □Pearson’s χ2 test
MUST, Malnutrition Universal Screening Tool; HFRS, Hospital Frailty Risk Score; SEIFA IRSD, Socioeconomic Indexes for Areas, Index of Relative Socioeconomic Disadvantage; LOS, length of stay
MUST | Low risk (N = 17 547) | Intermediate risk (N = 1899) | High risk (N = 2530) | P value | |||||
Baseline characteristic | |||||||||
Age mean (SD)● | 55.9 (20.4) | 57.6 (20.4) | 55.9 (20.4) | .002 | |||||
Sex (female) N (%)□ | 7229 (41.2) | 765 (40.3) | 1043 (41.2) | .74 | |||||
Charlson comorbidity index mean (SD)● | 3.7 (1.9) | 3.6 (1.8) | 3.8 (2.0) | .002 | |||||
HFRS mean (SD)● | 4.7 (4.3) | 4.4 (4.2) | 5.0 (4.4) | <.001 | |||||
Indigenous statusa (N)%□ | 779 (4.4) | 95 (5.0) | 219 (8.7) | <.001 | |||||
SEIFA IRSD decile mean (SD)● | 4.6 (2.8) | 4.5 (2.6) | 4.3 (2.9) | <.001 | |||||
Outcome | |||||||||
Low vs intermediate Mean ratio/odds ratio (95% CI) | P value | High vs intermediate Mean ratio/odds ratio (95% CI) | P value | High vs low Mean ratio/odds ratio (95% CI) | P value | ||||
LOS hours mean (SD) unadjusted | 155.2 (220.3) | 210.3 (323.2) | 0.83 (0.79, 0.87) | <.001 | 263.3 (355.9) | 1.20 (1.13, 1.27) | <.001 | 1.44 (1.39, 1.50) | <.001 |
LOS hours mean (SD) adjusted | 0.88 (0.84, 0.91) | <.001 | 1.13 (1.07, 1.19) | <.001 | 1.29 (1.25, 1.34) | <.001 | |||
30-Day readmission, N (%) unadjusted | 3500 | 436 | 0.90 (0.88, 0.91) | <.001 | 748 | 1.34 (1.23, 1.46) | <.001 | 1.50 (1.36, 1.65) | <.001 |
30-Day readmission, N (%) adjusted | 0.97 (0.89, 1.04) | .37 | 1.24 (1.18, 1.30) | <.001 | 1.29 (1.16, 1.42) | <.001 | |||
Inpatient mortality, N (%) unadjusted | 101 | 18 | 0.74 (0.63, 0.89) | .0008 | 53 | 1.86 (1.60, 2.17) | <.001 | 2.50 (2.10, 2.98) | <.001 |
Inpatient mortality, N (%) adjusted | 0.87 (0.76, 1.00) | .05 | 1.35 (1.12, 1.64) | .002 | 1.55 (1.26, 1.91) | <.001 |
MUST | Low risk (N = 17 547) | Intermediate risk (N = 1899) | High risk (N = 2530) | P value | |||||
Baseline characteristic | |||||||||
Age mean (SD)● | 55.9 (20.4) | 57.6 (20.4) | 55.9 (20.4) | .002 | |||||
Sex (female) N (%)□ | 7229 (41.2) | 765 (40.3) | 1043 (41.2) | .74 | |||||
Charlson comorbidity index mean (SD)● | 3.7 (1.9) | 3.6 (1.8) | 3.8 (2.0) | .002 | |||||
HFRS mean (SD)● | 4.7 (4.3) | 4.4 (4.2) | 5.0 (4.4) | <.001 | |||||
Indigenous statusa (N)%□ | 779 (4.4) | 95 (5.0) | 219 (8.7) | <.001 | |||||
SEIFA IRSD decile mean (SD)● | 4.6 (2.8) | 4.5 (2.6) | 4.3 (2.9) | <.001 | |||||
Outcome | |||||||||
Low vs intermediate Mean ratio/odds ratio (95% CI) | P value | High vs intermediate Mean ratio/odds ratio (95% CI) | P value | High vs low Mean ratio/odds ratio (95% CI) | P value | ||||
LOS hours mean (SD) unadjusted | 155.2 (220.3) | 210.3 (323.2) | 0.83 (0.79, 0.87) | <.001 | 263.3 (355.9) | 1.20 (1.13, 1.27) | <.001 | 1.44 (1.39, 1.50) | <.001 |
LOS hours mean (SD) adjusted | 0.88 (0.84, 0.91) | <.001 | 1.13 (1.07, 1.19) | <.001 | 1.29 (1.25, 1.34) | <.001 | |||
30-Day readmission, N (%) unadjusted | 3500 | 436 | 0.90 (0.88, 0.91) | <.001 | 748 | 1.34 (1.23, 1.46) | <.001 | 1.50 (1.36, 1.65) | <.001 |
30-Day readmission, N (%) adjusted | 0.97 (0.89, 1.04) | .37 | 1.24 (1.18, 1.30) | <.001 | 1.29 (1.16, 1.42) | <.001 | |||
Inpatient mortality, N (%) unadjusted | 101 | 18 | 0.74 (0.63, 0.89) | .0008 | 53 | 1.86 (1.60, 2.17) | <.001 | 2.50 (2.10, 2.98) | <.001 |
Inpatient mortality, N (%) adjusted | 0.87 (0.76, 1.00) | .05 | 1.35 (1.12, 1.64) | .002 | 1.55 (1.26, 1.91) | <.001 |
aInclusive of ‘Aboriginal’, ‘Aboriginal and Torres Strait Islander’ and ‘Torres Strait Islander’
●Analysis of variance, □Pearson’s χ2 test
MUST, Malnutrition Universal Screening Tool; HFRS, Hospital Frailty Risk Score; SEIFA IRSD, Socioeconomic Indexes for Areas, Index of Relative Socioeconomic Disadvantage; LOS, length of stay
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.